Neuralink's scaling into mass production mode. The company is gearing up to ramp up brain-computer interface device manufacturing while completely overhauling its surgical approach—think near-total automation taking over in 2026. It's a major pivot from the current manual-heavy procedures. What does this mean? Faster iterations, lower costs, broader accessibility. The shift signals serious confidence in the technology's viability. Whether this timeline holds or slips remains to be seen, but the direction is unmistakable: Neuralink is betting big on industrialization.